These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 15791810)

  • 1. [Myelodysplastic syndrome].
    Urabe A
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory anemia and the myelodysplastic syndromes.
    Lawrence LW
    Clin Lab Sci; 2004; 17(3):178-86. PubMed ID: 15314893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I; Ruiz MA; Cabello A; Collado R; Ferrer R; Hueso J; Martinez J; Miguel A; Orero MT; Pérez P; Nolasco A; Carbonell F
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myelodysplastic syndromes: classification and prognosis.
    Komrokji R; Bennett JM
    Curr Hematol Rep; 2003 May; 2(3):179-85. PubMed ID: 12901338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM
    Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
    Deeg HJ
    Leuk Res; 2004 Jun; 28(6):543-4. PubMed ID: 15120927
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelodysplastic diseases in childhood].
    Niemeyer C; Stollmann-Gibbels B; Ebell W; Gaedicke G; Creutzig U
    Klin Padiatr; 1992; 204(4):190-7. PubMed ID: 1518255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myelodysplastic syndrome classification].
    Ghariani I; Braham N; Hassine M; Kortas M
    Ann Biol Clin (Paris); 2013; 71(2):139-44. PubMed ID: 23587576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined stratification of refractory anemia according to both WHO and IPSS criteria has a prognostic impact and improves identification of patients who may benefit from stem cell transplantation.
    Cermák J; Vítek A; Michalová K
    Leuk Res; 2004 Jun; 28(6):551-7. PubMed ID: 15120930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myelodysplastic syndromes].
    Sainty D; Horschowski N; Fossat C; Sampol J
    Ann Biol Clin (Paris); 1985; 43(6):821-30. PubMed ID: 3914223
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes.
    Aul C; Giagounidis A; Heinsch M; Germing U; Ganser A
    Rev Clin Exp Hematol; 2004 Dec; 8(2):E1. PubMed ID: 16027099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndrome in children and adolescents.
    Niemeyer CM; Baumann I
    Semin Hematol; 2008 Jan; 45(1):60-70. PubMed ID: 18179970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical implications of the World Health Organization's classification of myelodysplastic syndromes.
    Komrokji RS; Bennett JM
    Curr Hematol Rep; 2005 May; 4(3):175-81. PubMed ID: 15865868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
    Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
    Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis in the myelodysplastic syndrome].
    Hunstein W; Ho AD
    Dtsch Med Wochenschr; 1987 Jan; 112(2):60-2. PubMed ID: 3542464
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myelodysplastic syndromes--new treatment options].
    Germing U
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():123-6. PubMed ID: 16802536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndromes. A clinico-biological analysis of 27 cases].
    Mereuţă A; Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(1):67-73. PubMed ID: 2075337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.